483 Sumitomo Dainippon Pharma Feb 2017

483 Sumitomo Dainippon Pharma Feb 2017

Angela Glenn FDA$119.00 - Available Now

FDA investigators audited the Sumitomo Dainippon Pharma - Oita, Japan facility and issued inspectional observations (via FDA 483) on 17 Feb 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Feb 2017
  • Location: Oita, Japan
  • FEI: 3005619533
Add To Cart